glp 1 drugs for parkinson's disease Are we measuring the wrong primary outcome GLP-1 for Parkinson's? Spoiler alert: the pooled data suggests we should pivot away from a motor outcome. Should we think cognitive, autonomic, sleep GLP-1s are everywhere, but why?
Pay in 4 interest-free payments of $5.60 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
















/assets/production/practices/e626fbe66fe89e763def7d30ea6f7b65458b8e71/images/2824932.jpg)










